Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2026-01-04 @ 12:39 PM
Study NCT ID:
NCT05457257
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2022-07-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-11
First Submit QC Date:
None
Study First Post Date:
2022-07-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-22
Results First Submit QC Date:
None
Results First Post Date:
2025-12-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED